Melkozerov K V, Przhiyalkovskaya E G, Tarbaeva N V, Almaskhanova A A, Kuklina M D, Alferova P A, Gomova I S, Belousov L A, Belaya Z E, Vorontsov A V, Kalashnikov V Y
Endocrinology Research Centre.
Ter Arkh. 2020 Nov 24;92(10):70-77. doi: 10.26442/00403660.2020.10.000787.
Cardiovascular complications including arrhythmias and cardiac conduction disorders are one of the main reasons of high mortality rate in acromegaly, while they have not been well explored.
To estimate arrhythmias frequency in acromegaly, identify risk factors leading to the development of arrhythmia and cardiac conduction disorder, to determine the role of cardiac MRI in detecting structural and functional changes.
A single-center prospective cohort study, which included 461 patients (151 men and 310 women) with acromegaly, was conducted. All the patients underwent a standard medical examination, including hormonal blood test, electrocardiogram, echocardiography, electrocardiogram daily monitoring. 18 patients with arrhythmias (11 men and 7 women) had cardiac MRI with gadolinium-based contrast.
The results of our research show high frequency of arrhythmias and cardiac conduction disorders in patients with acromegaly 42%. Most frequent kinds of arrhythmias and cardiac conduction disorders were sinus bradycardia 19.1% of the cases and conduction disorders of bundle branch blocks 14.5%. Men were more likely to suffer from arrhythmias and cardiac conduction disorders than women (54.2% and 37.4%, respectively,p=0.0005). Not acromegaly activity but duration of the disease was a main risk factor of arrhythmias and cardiac conduction disorders. Patients with arrhythmias had a long anamnesis of acromegaly (10 and 7 years, respectively, p=0.04). Meanwhile, cardiac conduction disorders were commonly observed in the patients who were treated with somatostatin analogs comparing to the patients who didnt undergo this therapy (50% and 38.6% respectively,p=0.004). We showed that 61% of patients with acromegaly and cardiac conduction disorders who underwent magnetic resonance imaging (MRI) had the signs of myocardial fibrosis. The value of the ejection fraction of the left ventricle according to MRI was higher than with echocardiography (p=0.04).
Arrhythmias and cardiac conduction disorders are often observed in patients with acromegaly even with remission of the disease. High risk group need careful diagnostic and monitoring approaches. Cardiac MRI is the gold standard for visualization of structural and morphological changes in the heart. Use of cardiac MRI in acromegalic patients expands our understanding of arrhythmias and cardiac conduction disorders in this disease. There are no specific laboratory markers of diffuse myocardial fibrosis, and the role of myocardial fibrosis in the occurrence of cardiac arrhythmias and conduction disorders needs further studying.
心血管并发症,包括心律失常和心脏传导障碍,是肢端肥大症高死亡率的主要原因之一,但尚未得到充分研究。
评估肢端肥大症患者心律失常的发生率,确定导致心律失常和心脏传导障碍发生的危险因素,明确心脏磁共振成像在检测结构和功能变化中的作用。
开展了一项单中心前瞻性队列研究,纳入461例肢端肥大症患者(151例男性和310例女性)。所有患者均接受了标准医学检查,包括血液激素检测、心电图、超声心动图、动态心电图监测。18例心律失常患者(11例男性和7例女性)接受了基于钆对比剂的心脏磁共振成像检查。
我们的研究结果显示,肢端肥大症患者心律失常和心脏传导障碍的发生率较高,为42%。最常见的心律失常和心脏传导障碍类型为窦性心动过缓(占病例的19.1%)和束支传导阻滞(占14.5%)。男性比女性更容易发生心律失常和心脏传导障碍(分别为54.2%和37.4%,p=0.0005)。导致心律失常和心脏传导障碍的主要危险因素不是肢端肥大症的活动情况,而是疾病持续时间。有心律失常的患者肢端肥大症病史较长(分别为10年和7年,p=0.04)。同时,与未接受该治疗的患者相比,接受生长抑素类似物治疗的患者中常见心脏传导障碍(分别为50%和38.6%,p=0.004)。我们发现,接受磁共振成像(MRI)检查的肢端肥大症合并心脏传导障碍患者中,61%有心肌纤维化迹象。根据MRI测得的左心室射血分数值高于超声心动图测得的值(p=0.04)。
即使疾病缓解,肢端肥大症患者也常出现心律失常和心脏传导障碍。高危人群需要仔细的诊断和监测方法。心脏MRI是可视化心脏结构和形态变化的金标准。在肢端肥大症患者中使用心脏MRI扩展了我们对该疾病中心律失常和心脏传导障碍的认识。目前尚无弥漫性心肌纤维化的特异性实验室标志物,心肌纤维化在心脏心律失常和传导障碍发生中的作用需要进一步研究。